These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37924689)

  • 41. Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome
    Li L; Cui H; Li T; Qi J; Chen H; Gao F; Tian X; Mu Y; He R; Lv S; Chu F; Xu B; Wang P; Lei H; Xu H; Wang C
    Front Pharmacol; 2020; 11():1210. PubMed ID: 32982718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier.
    Feng T; Zhou Y; Lv B; Cai L
    Drug Des Devel Ther; 2024; 18():3191-3208. PubMed ID: 39081703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway.
    Tan X; Pei W; Xie C; Wang Z; Liu J; Cheng Y; Mao T; Shi L; Zhao X; Lu Q; Sun Z; Kou F; Jiang H; Li J
    Evid Based Complement Alternat Med; 2021; 2021():6679348. PubMed ID: 34239591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LMWP (S3-3) from the Larvae of
    Peng S; Ling X; Rui W; Jin X; Chu F
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
    Xu XJ; Liu L; Yao SK
    J Zhejiang Univ Sci B; 2016 Jan; 17(1):1-9. PubMed ID: 26739521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
    Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
    Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome.
    Salvo-Romero E; Martínez C; Lobo B; Rodiño-Janeiro BK; Pigrau M; Sánchez-Chardi AD; González-Castro AM; Fortea M; Pardo-Camacho C; Nieto A; Expósito E; Guagnozzi D; Rodríguez-Urrutia A; de Torres I; Farré R; Azpiroz F; Alonso-Cotoner C; Santos J; Vicario M
    Sci Rep; 2020 Nov; 10(1):20706. PubMed ID: 33244004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of acupuncture-moxibustion stimulation of combined "Biao-Ben" acupoints on autonomic nervous activity and related factors in rats with irritable bowel syndrome diarrhea].
    Zhou XL; Wang H; Li J; Wu S; Wu F; Lu W; Fu YM
    Zhen Ci Yan Jiu; 2023 Jul; 48(7):635-42. PubMed ID: 37518956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on the mechanism of electroacupuncture repairing intestinal barrier via regulating mast cell in rats with diarrhea-predominant irritable bowel syndrome].
    Hou YJ; Wang K; Jiang HL; Chen Y; Yao JP; Li Y; Zhou SY
    Zhen Ci Yan Jiu; 2023 Mar; 48(3):281-6. PubMed ID: 36951081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic Sacral Nerve Stimulation Inhibits Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats Model.
    Guo X; Lei C; Liang H; An J; Fang Y; Zhang X; Wang Z; Hu C; Jiang X
    Neuromodulation; 2024 Feb; 27(2):295-301. PubMed ID: 37930296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SAHA Alleviates Diarrhea-Predominant Irritable Bowel Syndrome Through Regulation of the p-STAT3/SERT/5-HT Signaling Pathway.
    Shen J; Zhang B; Chen J; Cheng J; Wang J; Zheng X; Lan Y; Zhang X
    J Inflamm Res; 2022; 15():1745-1756. PubMed ID: 35300211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea.
    Ke W; Wu J; Li H; Huang S; Li H; Wang Y; Wu Y; Yuan J; Zhang S; Tang H; Lei K
    Heliyon; 2024 Jun; 10(12):e33102. PubMed ID: 39005919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1.
    Zhu H; Xiao X; Shi Y; Wu Y; Huang Y; Li D; Xiong F; He G; Chai Y; Tang H
    Exp Ther Med; 2020 Dec; 20(6):155. PubMed ID: 33093893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology.
    Tan X; Zhao XJ; Li JX; Xie CE; Pei WJ; Shi L; Kou FS; Yuan YL; Xue XX
    Medicine (Baltimore); 2020 Dec; 99(52):e23868. PubMed ID: 33350782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS.
    Fichna J; Sobczak M; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Cenac N; Sałaga M; Timmermans JP; Vergnolle N; Małecka-Panas E; Krajewska WM; Storr M
    Neurogastroenterol Motil; 2014 Nov; 26(11):1539-50. PubMed ID: 25041572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.
    Wu RL; Vazquez-Roque MI; Carlson P; Burton D; Grover M; Camilleri M; Turner JR
    Lab Invest; 2017 Jan; 97(1):14-23. PubMed ID: 27869798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome].
    Zhu J; Luo HS; Chen L; Zhou T
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2713-7. PubMed ID: 20137275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.